Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommon
Maria J. Valkema(Erasmus University Rotterdam), J. Jan B. van Lanschot(Erasmus MC Cancer Institute), Jolanda M. van Dieren(The Netherlands Cancer Institute), Pieter C. van der Sluis(University Medical Center Utrecht), G Willemien Erkelens(Gelre Hospitals), Liekele E. Oostenbrug(Zuyderland Medisch Centrum), Erik J. Schoon(Radboud University Nijmegen), Manon C.W. Spaander(Erasmus University Rotterdam), Bas P. L. Wijnhoven(Erasmus MC Cancer Institute), Rutger Quispel(Reinier de Graaf Hospital), Sjoerd M. Lagarde(University of Amsterdam), Peter D. Siersema(University Medical Center Utrecht), Ben M. Eyck(Erasmus MC Cancer Institute), A. Van der Linden(Ziekenhuis Groep Twente), Jurjen J. Boonstra(Leiden University Medical Center), Michail Doukas(Erasmus MC), K Linde(Medisch Centrum Leeuwarden), Berend J. van der Wilk(Erasmus MC Cancer Institute), Wouter L. Hazen(Elisabeth-TweeSteden Ziekenhuis), Ingrid L. Holster(Maasstad Ziekenhuis)
Cited by 8
Related Papers
Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus
|New England Journal of Medicine|2002|1.6k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|788
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|715